NRAS and acral lentiginous melanoma: In Taiwan, NRAS/KRAS mutations, cell cycle aberrations, increased copy numbers in antiapoptotic genes BIRC2, BIRC3, and BIRC5, and the amplification of receptor tyrosine kinase genes were significantly enriched in acral melanoma [54].